Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Cancer Prev Res (Phila). 2012 May 3;5(6):822–833. doi: 10.1158/1940-6207.CAPR-11-0559

Table 1.

Potency of SS and SBA to inhibit cAMP and cGMP hydrolysis by PDE isozymes

SBA sensitivity
SS sensitivity
PDE family Substrate cGMP IC50, μmol/L cAMP IC50, μmol/L cGMP IC50, μmol/L cAMP IC50, μmol/L
1A cAMP/cGMP >100 >100 >100 >100
1B cAMP/cGMP >100 >100 >100 >100
1C cAMP/cGMP >100 >100 >100 >100
2A cAMP/cGMP >100 >100 97 >100
3A cAMP/cGMP >100 >100 84 >100
3B cAMP/cGMP >100 >100 >100 >100
4B cAMP ND 75 ND >100
5A cGMP 9 ND 38 ND
6C cGMP >100 ND >100 ND
7A cAMP ND >100 ND >100
8A cAMP ND >100 ND >100
9A cGMP >100 ND >100 ND
10A cAMP/cGMP 62 77 70 >100
11A cAMP/cGMP >100 >100 >100 >100

Abbreviation: ND, not determined.